Legal Representation
Attorney
Mark I. Feldman and Christina L. Martini
USPTO Deadlines
Application History
26 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 20, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Dec 20, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Aug 17, 2007 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
May 3, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 3, 2007 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jan 27, 2007 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Nov 30, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 30, 2006 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Sep 26, 2006 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
May 24, 2006 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
May 12, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 12, 2006 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Dec 21, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Nov 30, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 30, 2005 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
May 31, 2005 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Mar 8, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 16, 2005 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Dec 7, 2004 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Dec 6, 2004 | ALIE | A | ASSIGNED TO LIE | Loading... |
Nov 30, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 28, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
Nov 15, 2004 | I | PAPER RECEIVED | Loading... | |
Nov 15, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 11, 2004 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 27, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment of oncological diseases and disorders and complications associated therewith
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
HUMAN BLOCKS
Classification
International Classes
005